海得控制(002184.SZ):回購註銷86.104萬股限制性股票
格隆匯 6 月 19日丨海得控制(002184.SZ)公佈,根據《公司2016年限制性股票激勵計劃(草案)》的規定,因2019年度公司財務業績考核未達標,對應的首次授予部分第三個解除限售期的限制性股票不滿足解除限售條件,47名激勵對象考核當年可解除限售的限制性股票共計861,040股均不得解除限售,由公司回購註銷。
本次限制性股票回購註銷的限制性股票合計86.104萬股,佔回購註銷前上海海得控制系統股份有限公司(以下簡稱“公司”)總股本的0.36%,本次限制性股票回購價格為11.54元/股。
截至2020年6月19日,上述限制性股票已在中國證券登記結算有限責任公司深圳分公司完成註銷手續。
Follow us
Find us on
Facebook,
Twitter ,
Instagram, and
YouTube or frequent updates on all things investing.Have a financial topic you would like to discuss? Head over to the
uSMART Community to share your thoughts and insights about the market! Click the picture below to download and explore uSMART app!

Disclaimers
uSmart Securities Limited (“uSmart”) is based on its internal research and public third party information in preparation of this article. Although uSmart uses its best endeavours to ensure the content of this article is accurate, uSmart does not guarantee the accuracy, timeliness or completeness of the information of this article and is not responsible for any views/opinions/comments in this article. Opinions, forecasts and estimations reflect uSmart’s assessment as of the date of this article and are subject to change. uSmart has no obligation to notify you or anyone of any such changes. You must make independent analysis and judgment on any matters involved in this article. uSmart and any directors, officers, employees or agents of uSmart will not be liable for any loss or damage suffered by any person in reliance on any representation or omission in the content of this article. The content of the article is for reference only and does not constitute any offer, solicitation, recommendation, opinion or guarantee of any securities, virtual assets, financial products or instruments. Regulatory authorities may restrict the trading of virtual asset-related ETFs to only investors who meet specified requirements. Any calculations or images in the article are for illustrative purposes only.
Investment involves risks and the value and income from securities may rise or fall. Past performance is not indicative of future performance. Please carefully consider your personal risk tolerance, and consult independent professional advice if necessary.